Fintel reports that on December 16, 2024, B of A Securities upgraded their outlook for Edwards Lifesciences (XTRA:EWL) from Neutral to Buy.
Analyst Price Forecast Suggests 3.07% Upside
As of December 3, 2024, the average one-year price target for Edwards Lifesciences is 72,60 €/share. The forecasts range from a low of 60,12 € to a high of 89,28 €. The average price target represents an increase of 3.07% from its latest reported closing price of 70,44 € / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Edwards Lifesciences is 6,638MM, an increase of 5.12%. The projected annual non-GAAP EPS is 2.94.
What is the Fund Sentiment?
There are 2,409 funds or institutions reporting positions in Edwards Lifesciences. This is an decrease of 86 owner(s) or 3.45% in the last quarter. Average portfolio weight of all funds dedicated to EWL is 0.26%, an increase of 42.09%. Total shares owned by institutions decreased in the last three months by 54.22% to 545,580K shares.
What are Other Shareholders Doing?
Wellington Management Group Llp holds 31,533K shares representing 5.35% ownership of the company. In its prior filing, the firm reported owning 16,923K shares , representing an increase of 46.33%. The firm decreased its portfolio allocation in EWL by 81.69% over the last quarter.
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 19,120K shares representing 3.24% ownership of the company. In its prior filing, the firm reported owning 18,998K shares , representing an increase of 0.64%. The firm decreased its portfolio allocation in EWL by 32.47% over the last quarter.
Bank of New York Mellon holds 18,306K shares representing 3.10% ownership of the company. In its prior filing, the firm reported owning 19,783K shares , representing a decrease of 8.07%. The firm decreased its portfolio allocation in EWL by 93.31% over the last quarter.
VFINX - Vanguard 500 Index Fund Investor Shares holds 15,777K shares representing 2.67% ownership of the company. In its prior filing, the firm reported owning 15,466K shares , representing an increase of 1.97%. The firm decreased its portfolio allocation in EWL by 32.93% over the last quarter.
Geode Capital Management holds 13,521K shares representing 2.29% ownership of the company. In its prior filing, the firm reported owning 13,236K shares , representing an increase of 2.11%. The firm decreased its portfolio allocation in EWL by 64.76% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
